Advanced biological and chemical discovery (ABCD): Centralizing discovery knowledge in an inherently decentralized world

被引:62
|
作者
Agrafiotis, Dimitris K.
Alex, Simson
Dai, Heng
Derkinderen, An
Farnum, Michael
Gates, Peter
Izrailev, Sergei
Jaeger, Edward P.
Konstant, Paul
Leung, Albert
Lobanov, Victor S.
Marichal, Patrick
Martin, Douglas
Rassokhin, Dmitrii N.
Shemanarev, Maxim
Skalkin, Andrew
Stong, John
Tabruyn, Tom
Vermeiren, Marleen
Wan, Jackson
Xu, Xiang Yang
Yao, Xiang
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Exton, PA 19341 USA
[2] Johnson & Johnson Pharmaceut Res & Dev, Div Janssen Pharmaceut NV, B-2340 Beerse, Belgium
[3] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA
关键词
D O I
10.1021/ci700267w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We present ABCD, an integrated drug discovery informatics platform developed at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ABCD is an attempt to bridge multiple continents, data systems, and cultures using modern information technology and to provide scientists with tools that allow them to analyze multifactorial SAR and make informed, data-driven decisions. The system consists of three major components: (1) a data warehouse, which combines data from multiple chemical and pharmacological transactional databases, designed for supreme query performance; (2) a state-of-the-art application suite, which facilitates data upload, retrieval, mining, and reporting, and (3) a workspace, which facilitates collaboration and data sharing by allowing users to share queries, templates, results, and reports across project teams, campuses, and other organizational units. Chemical intelligence, performance, and analytical sophistication lie at the heart of the new system, which was developed entirely in-house. ABCD is used routinely by more than 1000 scientists around the world and is rapidly expanding into other functional areas within the J&J organization.
引用
收藏
页码:1999 / 2014
页数:16
相关论文
共 50 条
  • [41] Domain-driven actionable knowledge discovery in the real world
    Cao, LB
    Zhang, CQ
    ADVANCES IN KNOWLEDGE DISCOVERY AND DATA MINING, PROCEEDINGS, 2006, 3918 : 821 - 830
  • [42] Exploring biological and chemical space: the new dimension of drug discovery
    Blundell, T.
    FEBS JOURNAL, 2008, 275 : 23 - 23
  • [43] The Race for Chemical and Biological Space: Drug Discovery and Innovative Technologies
    Sawyer, Tomi K.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (01) : 1 - 2
  • [44] Structural pharmacology and drug discovery: Exploring biological and chemical space
    Blundell, Tom L.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C10 - C10
  • [45] MANAGING INFORMATION IN DRUG DISCOVERY - LINKING CHEMICAL AND BIOLOGICAL DATA
    VANDRIE, JH
    KU, SLL
    BEREZIN, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 23 - CINF
  • [46] Integration of genomic, biological, and chemical data in drug discovery.
    Laz, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U351 - U352
  • [47] Marine natural products synthesis: A platform for chemical and biological discovery
    Pierce, Joshua
    Shymanska, Nataliia
    Edwards, Grant
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [48] Knowledge discovery on chemical reactivity from experimental reaction information
    Satoh, H
    Nakata, T
    DISCOVERY SCIENCE, PROCEEDINGS, 2003, 2843 : 470 - 477
  • [49] Marine natural product synthesis: A platform for chemical and biological discovery
    Pierce, Joshua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [50] Knowledge discovery on chemical reactivity from experimental reaction information
    Satoh, Hiroko
    Nakata, Tadashi
    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 2003, 2843 : 470 - 477